The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...